Showing 201 - 220 results of 54,882 for search '(( 50 ((ppm decrease) OR (nn decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 0.83s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211

    Decreased Tks5 expression results in neural crest-derived defects. by Danielle A. Murphy (212554)

    Published 2011
    “…(C) Melanophores present in the dorsal, ventral, and lateral pigment lines were quantified to determine degree of murine Tks5 rescue of the decreased pigmentation seen in morphants. …”
  12. 212

    Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

    Published 2013
    “…Furthermore, symbols and numbers are consistently used for the same subject in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-g004" target="_blank">Figures 4</a> & <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-g005" target="_blank">5</a>. Mean metabolite abundance±SEM is indicated in red. …”
  13. 213
  14. 214
  15. 215
  16. 216

    Total number of identified bone proteins with differences in abundance in each comparison, by label-free semi-quantitative differential expression analysis. by Cláudia A. N. Kobayashi (673416)

    Published 2014
    “…Significant differences in protein abundance were considered when ratio ≤0.5 or ≥1.5. Ratios of ≤0.5 or ≥1.5 mean increase or decrease in group B in relation to group A, respectively.…”
  17. 217
  18. 218
  19. 219

    S1 Data - by Toru Hosokawa (364158)

    Published 2023
    Subjects:
  20. 220

    Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

    Published 2011
    “…Kidney angiomyolipomas regrew when sirolimus was discontinued but responses tended to persist if treatment was continued after week 52. We observed regression of brain tumors (SEGAs) in 7/11 cases (26% mean decrease in diameter), regression of liver angiomyolipomas in 4/5 cases (32.1% mean decrease in longest diameter), subjective improvement in facial angiofibromas in 57%, and stable lung function in women with TSC/LAM (n = 15). …”